Loading…

Ergotamine-associated valvulopathy with recurrent chylous pleural effusion

We report a rare case of ergotamine-associated mitral stenosis in a 55-year-old woman who presented with recurrent chylous pleural effusion. Echocardiographic, gross, and microscopic features of the mitral valve were consistent with chronic ergotamine-induced valvulopathy. We conclude that medicatio...

Full description

Saved in:

Bibliographic Details
Published in:	Texas Heart Institute journal 2012-01, Vol.39 (5), p.736-738
Main Authors:	Bois, John P, Ponnada, Vara Venkata, O'Cochlain, D Fearghas, Brady, Peter A, Edwards, William D, Klarich, Kyle W
Format:	Article
Language:	English
Subjects:	Case Reports Chylothorax - chemically induced Chylothorax - diagnosis Dopamine Agonists - adverse effects Echocardiography, Doppler, Color Echocardiography, Transesophageal Ergotamine - adverse effects Female Heart Valve Prosthesis Implantation Humans Middle Aged Mitral Valve Stenosis - chemically induced Mitral Valve Stenosis - diagnosis Mitral Valve Stenosis - surgery Pleural Effusion - chemically induced Pleural Effusion - diagnosis Predictive Value of Tests Recurrence Treatment Outcome
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by
cites
container_end_page	738
container_issue	5
container_start_page	736
container_title	Texas Heart Institute journal
container_volume	39
creator	Bois, John P Ponnada, Vara Venkata O'Cochlain, D Fearghas Brady, Peter A Edwards, William D Klarich, Kyle W
description	We report a rare case of ergotamine-associated mitral stenosis in a 55-year-old woman who presented with recurrent chylous pleural effusion. Echocardiographic, gross, and microscopic features of the mitral valve were consistent with chronic ergotamine-induced valvulopathy. We conclude that medication-induced valvulopathy should be included in the differential diagnosis of valvular heart disease. In addition, cardiac function should be monitored before and during long-term therapy with ergotamine or ergotamine-derived dopamine agonists.
format	article
fullrecord	<record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3461660</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>23109782</sourcerecordid><originalsourceid>FETCH-LOGICAL-p266t-4705f9b8b540088f05011c77c78cd88ea7697899eb65765302834e1a683955513</originalsourceid><addsrcrecordid>eNpVkMtKxDAYhYMoTh19BekLFP4kzaUbQYZRRwbc6LqkaTqNtE1Jmkrf3oIXdHUWh_Pxcc5QghnhGRdAzlECgkJGaC426CqEdwCgBJNLtCEUQyEkSdDz3p_cpHo7mEyF4LRVk6nTWXVz7NyopnZJP-zUpt7o6L0ZplS3S-diSMfORK-61DRNDNYN1-iiUV0wN9-5RW8P-9fdU3Z8eTzs7o_ZSDifslwAa4pKViwHkLIBBhhrIbSQupbSKMFXtaIwFWeCMwpE0txgxSUtGGOYbtHdF3eMVW9qvTqtGuXoba_8Ujply__NYNvy5OaS5hxzDivg9i_gd_nzCv0EOaJgxg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Ergotamine-associated valvulopathy with recurrent chylous pleural effusion</title><source>PubMed Central (Open access)</source><creator>Bois, John P ; Ponnada, Vara Venkata ; O'Cochlain, D Fearghas ; Brady, Peter A ; Edwards, William D ; Klarich, Kyle W</creator><creatorcontrib>Bois, John P ; Ponnada, Vara Venkata ; O'Cochlain, D Fearghas ; Brady, Peter A ; Edwards, William D ; Klarich, Kyle W</creatorcontrib><description>We report a rare case of ergotamine-associated mitral stenosis in a 55-year-old woman who presented with recurrent chylous pleural effusion. Echocardiographic, gross, and microscopic features of the mitral valve were consistent with chronic ergotamine-induced valvulopathy. We conclude that medication-induced valvulopathy should be included in the differential diagnosis of valvular heart disease. In addition, cardiac function should be monitored before and during long-term therapy with ergotamine or ergotamine-derived dopamine agonists.</description><identifier>ISSN: 0730-2347</identifier><identifier>EISSN: 1526-6702</identifier><identifier>PMID: 23109782</identifier><language>eng</language><publisher>United States: Texas Heart Institute</publisher><subject>Case Reports ; Chylothorax - chemically induced ; Chylothorax - diagnosis ; Dopamine Agonists - adverse effects ; Echocardiography, Doppler, Color ; Echocardiography, Transesophageal ; Ergotamine - adverse effects ; Female ; Heart Valve Prosthesis Implantation ; Humans ; Middle Aged ; Mitral Valve Stenosis - chemically induced ; Mitral Valve Stenosis - diagnosis ; Mitral Valve Stenosis - surgery ; Pleural Effusion - chemically induced ; Pleural Effusion - diagnosis ; Predictive Value of Tests ; Recurrence ; Treatment Outcome</subject><ispartof>Texas Heart Institute journal, 2012-01, Vol.39 (5), p.736-738</ispartof><rights>2012 by the Texas Heart® Institute, Houston</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461660/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461660/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23109782$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bois, John P</creatorcontrib><creatorcontrib>Ponnada, Vara Venkata</creatorcontrib><creatorcontrib>O'Cochlain, D Fearghas</creatorcontrib><creatorcontrib>Brady, Peter A</creatorcontrib><creatorcontrib>Edwards, William D</creatorcontrib><creatorcontrib>Klarich, Kyle W</creatorcontrib><title>Ergotamine-associated valvulopathy with recurrent chylous pleural effusion</title><title>Texas Heart Institute journal</title><addtitle>Tex Heart Inst J</addtitle><description>We report a rare case of ergotamine-associated mitral stenosis in a 55-year-old woman who presented with recurrent chylous pleural effusion. Echocardiographic, gross, and microscopic features of the mitral valve were consistent with chronic ergotamine-induced valvulopathy. We conclude that medication-induced valvulopathy should be included in the differential diagnosis of valvular heart disease. In addition, cardiac function should be monitored before and during long-term therapy with ergotamine or ergotamine-derived dopamine agonists.</description><subject>Case Reports</subject><subject>Chylothorax - chemically induced</subject><subject>Chylothorax - diagnosis</subject><subject>Dopamine Agonists - adverse effects</subject><subject>Echocardiography, Doppler, Color</subject><subject>Echocardiography, Transesophageal</subject><subject>Ergotamine - adverse effects</subject><subject>Female</subject><subject>Heart Valve Prosthesis Implantation</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Mitral Valve Stenosis - chemically induced</subject><subject>Mitral Valve Stenosis - diagnosis</subject><subject>Mitral Valve Stenosis - surgery</subject><subject>Pleural Effusion - chemically induced</subject><subject>Pleural Effusion - diagnosis</subject><subject>Predictive Value of Tests</subject><subject>Recurrence</subject><subject>Treatment Outcome</subject><issn>0730-2347</issn><issn>1526-6702</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNpVkMtKxDAYhYMoTh19BekLFP4kzaUbQYZRRwbc6LqkaTqNtE1Jmkrf3oIXdHUWh_Pxcc5QghnhGRdAzlECgkJGaC426CqEdwCgBJNLtCEUQyEkSdDz3p_cpHo7mEyF4LRVk6nTWXVz7NyopnZJP-zUpt7o6L0ZplS3S-diSMfORK-61DRNDNYN1-iiUV0wN9-5RW8P-9fdU3Z8eTzs7o_ZSDifslwAa4pKViwHkLIBBhhrIbSQupbSKMFXtaIwFWeCMwpE0txgxSUtGGOYbtHdF3eMVW9qvTqtGuXoba_8Ujply__NYNvy5OaS5hxzDivg9i_gd_nzCv0EOaJgxg</recordid><startdate>20120101</startdate><enddate>20120101</enddate><creator>Bois, John P</creator><creator>Ponnada, Vara Venkata</creator><creator>O'Cochlain, D Fearghas</creator><creator>Brady, Peter A</creator><creator>Edwards, William D</creator><creator>Klarich, Kyle W</creator><general>Texas Heart Institute</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>5PM</scope></search><sort><creationdate>20120101</creationdate><title>Ergotamine-associated valvulopathy with recurrent chylous pleural effusion</title><author>Bois, John P ; Ponnada, Vara Venkata ; O'Cochlain, D Fearghas ; Brady, Peter A ; Edwards, William D ; Klarich, Kyle W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p266t-4705f9b8b540088f05011c77c78cd88ea7697899eb65765302834e1a683955513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Case Reports</topic><topic>Chylothorax - chemically induced</topic><topic>Chylothorax - diagnosis</topic><topic>Dopamine Agonists - adverse effects</topic><topic>Echocardiography, Doppler, Color</topic><topic>Echocardiography, Transesophageal</topic><topic>Ergotamine - adverse effects</topic><topic>Female</topic><topic>Heart Valve Prosthesis Implantation</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Mitral Valve Stenosis - chemically induced</topic><topic>Mitral Valve Stenosis - diagnosis</topic><topic>Mitral Valve Stenosis - surgery</topic><topic>Pleural Effusion - chemically induced</topic><topic>Pleural Effusion - diagnosis</topic><topic>Predictive Value of Tests</topic><topic>Recurrence</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bois, John P</creatorcontrib><creatorcontrib>Ponnada, Vara Venkata</creatorcontrib><creatorcontrib>O'Cochlain, D Fearghas</creatorcontrib><creatorcontrib>Brady, Peter A</creatorcontrib><creatorcontrib>Edwards, William D</creatorcontrib><creatorcontrib>Klarich, Kyle W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Texas Heart Institute journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bois, John P</au><au>Ponnada, Vara Venkata</au><au>O'Cochlain, D Fearghas</au><au>Brady, Peter A</au><au>Edwards, William D</au><au>Klarich, Kyle W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ergotamine-associated valvulopathy with recurrent chylous pleural effusion</atitle><jtitle>Texas Heart Institute journal</jtitle><addtitle>Tex Heart Inst J</addtitle><date>2012-01-01</date><risdate>2012</risdate><volume>39</volume><issue>5</issue><spage>736</spage><epage>738</epage><pages>736-738</pages><issn>0730-2347</issn><eissn>1526-6702</eissn><abstract>We report a rare case of ergotamine-associated mitral stenosis in a 55-year-old woman who presented with recurrent chylous pleural effusion. Echocardiographic, gross, and microscopic features of the mitral valve were consistent with chronic ergotamine-induced valvulopathy. We conclude that medication-induced valvulopathy should be included in the differential diagnosis of valvular heart disease. In addition, cardiac function should be monitored before and during long-term therapy with ergotamine or ergotamine-derived dopamine agonists.</abstract><cop>United States</cop><pub>Texas Heart Institute</pub><pmid>23109782</pmid><tpages>3</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0730-2347
ispartof	Texas Heart Institute journal, 2012-01, Vol.39 (5), p.736-738
issn	0730-2347 1526-6702
language	eng
recordid	cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3461660
source	PubMed Central (Open access)
subjects	Case Reports Chylothorax - chemically induced Chylothorax - diagnosis Dopamine Agonists - adverse effects Echocardiography, Doppler, Color Echocardiography, Transesophageal Ergotamine - adverse effects Female Heart Valve Prosthesis Implantation Humans Middle Aged Mitral Valve Stenosis - chemically induced Mitral Valve Stenosis - diagnosis Mitral Valve Stenosis - surgery Pleural Effusion - chemically induced Pleural Effusion - diagnosis Predictive Value of Tests Recurrence Treatment Outcome
title	Ergotamine-associated valvulopathy with recurrent chylous pleural effusion
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T11%3A02%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ergotamine-associated%20valvulopathy%20with%20recurrent%20chylous%20pleural%20effusion&rft.jtitle=Texas%20Heart%20Institute%20journal&rft.au=Bois,%20John%20P&rft.date=2012-01-01&rft.volume=39&rft.issue=5&rft.spage=736&rft.epage=738&rft.pages=736-738&rft.issn=0730-2347&rft.eissn=1526-6702&rft_id=info:doi/&rft_dat=%3Cpubmed%3E23109782%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p266t-4705f9b8b540088f05011c77c78cd88ea7697899eb65765302834e1a683955513%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/23109782&rfr_iscdi=true